Melatonin attenuates oxidative stress–induced ferroptosis of nucleus pulposus cells and intervertebral disc degeneration via PI3K/AKT-mTOR pathway
Authors:
Open Access
- 24 February 2026
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (5) , 11511-11525
Abstract
Background: Intervertebral disc degeneration (IVDD) is a leading cause of low back pain and disability. Ferroptosis, an iron-dependent form of regulated cell death driven by oxidative stress, plays a critical role in IVDD pathogenesis. Melatonin, a neurohormone with antioxidative properties, has shown potential protective effects, but its precise mechanism of action remains unclear. Methods: This study integrated multi-omics analyses, human NP specimens, cultured human NP cells, and a rat IVDD model induced by tert-butyl hydroperoxide (TBHP). Ferroptosis, oxidative stress, mitochondrial injury, and ECM metabolism were evaluated using histological staining, flow cytometry, ELISA, immunofluorescence, and western blotting. The involvement of melatonin receptors and PI3K/AKT-mTOR signaling was examined using pharmacological activation/blockade. Computational structural modeling was additionally employed to assess interactions between mTOR and ferroptosis-related proteins. Results: Melatonin significantly inhibited TBHP-induced ferroptosis in NP cells by restoring GSH levels, reducing Fe 2 ⁺ accumulation and ROS generation, preserving mitochondrial morphology, and upregulating SLC7A11 and GPX4. Melatonin also ameliorated ECM metabolic imbalance by increasing collagen II, aggrecan, and osteonectin, while suppressing MMP-9 and ADAMTS5. These protective effects were abolished by MT1/MT2 receptor antagonism or AKT phosphorylation inhibition, indicating pathway dependence. In vivo , melatonin attenuated disc degeneration, reduced apoptosis, restored ECM components, and normalized ferroptosis-related markers. Multi-omics datasets and structural modeling further supported that melatonin regulates ferroptosis through MT1/2-mediated activation of the PI3K/AKT-mTOR axis. Conclusions: Melatonin mitigates IVDD by suppressing ferroptosis and preserving ECM homeostasis through melatonergic receptor (MT1/MT2)–dependent activation of the PI3K/AKT–mTOR pathway. Notably, clinical and protein-level evidence suggests that MT1 may represent the predominant therapeutic target, supporting melatonin as a promising, low-toxicity candidate for delaying IVDD progression.Keywords
This publication has 43 references indexed in Scilit:
- Shared and Compartment‐Specific Processes in Nucleus Pulposus and Annulus Fibrosus During Intervertebral Disc DegenerationAdvanced Science, 2024
- Astaxanthin suppresses oxidative stress and calcification in vertebral cartilage endplate via activating Nrf-2/HO-1 signaling pathwayInternational Immunopharmacology, 2023
- Intervertebral disc degeneration and how it leads to low back painJOR SPINE, 2022
- Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applicationsCell, 2022
- Integrated analysis of multimodal single-cell dataCell, 2021
- Melatonin, an ubiquitous metabolic regulator: functions, mechanisms and effects on circadian disruption and degenerative diseasesReviews in Endocrine and Metabolic Disorders, 2020
- SIRT3 deficiency is resistant to autophagy‐dependent ferroptosis by inhibiting the AMPK/mTOR pathway and promoting GPX4 levelsJournal of Cellular Physiology, 2020
- Melatonin mediates mucosal immune cells, microbial metabolism, and rhythm crosstalk: A therapeutic target to reduce intestinal inflammationMedicinal Research Reviews, 2019
- Mechanisms of endogenous repair failure during intervertebral disc degenerationOsteoarthritis and Cartilage, 2019
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012